BioCentury | Oct 5, 2015
Financial News

PhageTech completes venture financing

PhageTech Inc. , Irvine, Calif. Business: Diagnostic Date completed: 2015-09-28 Type: Venture financing Raised: $2.4 million Investors: Mark IV Capital; Black River Investments WIR Staff Diagnostic...
BioCentury | Feb 14, 2005
Company News

Targanta Therapeutics Inc. infectious, functional genomics, proteomics news

...Targanta, formerly PhageTech, will restructure to focus on preclinical development. As a result, Targanta will decrease...
BioCentury | Jan 31, 2005
Company News

Neurochem management update

...Pharmaceuticals Group plc; and Daniel Delorme as VP of research, formerly VP of R&D at Phagetech...
BioCentury | Jun 7, 2004
Company News

Procyon management update

...Wu as VP of preclinical and basic research, formerly VP of research and development-biology at PhageTech...
BioCentury | Jan 19, 2004
Company News

PhageTech other research news

...screen for small molecule inhibitors, several of which inhibited both bacterial growth and DNA synthesis. PhageTech...
BioCentury | Oct 13, 2003
Emerging Company Profile

Corporate Profile

PhageTech Inc. Montreal, Quebec Technology: Discovery of anti-infectives based on bacteriophage genomes Disease focus: Bacterial infections Clinical status: NA Founded: 1997 by Jerry Pelletier, Philippe Gros and Michael DuBow Corporate partners: None University collaborators: None...
BioCentury | Oct 13, 2003
Emerging Company Profile

PhageTech: Classic phage-turner

...find new treatments have been only marginally successful due to a lack of new targets. PhageTech...
...Inc. is approaching the problem by taking lessons from an old pro - the bacteriophage. PhageTech...
...phage open reading frames (ORFs), which designate the base pair triplets (codons) for gene transcription. PhageTech...
BioCentury | Jun 30, 2003
Company News

PhageTech management update

PhageTech Inc. , Montreal, Quebec Business: Genomics, Infectious diseases Hired: Pierre Etienne as CEO and president, formerly VP of worldwide development operations at Pfizer Inc. ; he replaces Dalal Manoli WIR Staff Infectious...
BioCentury | Jun 23, 2003
Company News

PhageTech names Etienne CEO

...Antibacterial company PhageTech (Montreal, Quebec) hired Pierre Etienne as president and CEO. Etienne most recently was...
BioCentury | Mar 24, 2003
Company News

PhageTech board of directors update

PhageTech Inc. , Montreal, Quebec Business: Genomics, Infectious diseases Appointed: Francois Legault, former EVP of corporate development and investments at Biochem Pharma Inc., which is now part of Shire Pharmaceuticals Group plc; and Rene Kurth, senior...
Items per page:
1 - 10 of 16
BioCentury | Oct 5, 2015
Financial News

PhageTech completes venture financing

PhageTech Inc. , Irvine, Calif. Business: Diagnostic Date completed: 2015-09-28 Type: Venture financing Raised: $2.4 million Investors: Mark IV Capital; Black River Investments WIR Staff Diagnostic...
BioCentury | Feb 14, 2005
Company News

Targanta Therapeutics Inc. infectious, functional genomics, proteomics news

...Targanta, formerly PhageTech, will restructure to focus on preclinical development. As a result, Targanta will decrease...
BioCentury | Jan 31, 2005
Company News

Neurochem management update

...Pharmaceuticals Group plc; and Daniel Delorme as VP of research, formerly VP of R&D at Phagetech...
BioCentury | Jun 7, 2004
Company News

Procyon management update

...Wu as VP of preclinical and basic research, formerly VP of research and development-biology at PhageTech...
BioCentury | Jan 19, 2004
Company News

PhageTech other research news

...screen for small molecule inhibitors, several of which inhibited both bacterial growth and DNA synthesis. PhageTech...
BioCentury | Oct 13, 2003
Emerging Company Profile

Corporate Profile

PhageTech Inc. Montreal, Quebec Technology: Discovery of anti-infectives based on bacteriophage genomes Disease focus: Bacterial infections Clinical status: NA Founded: 1997 by Jerry Pelletier, Philippe Gros and Michael DuBow Corporate partners: None University collaborators: None...
BioCentury | Oct 13, 2003
Emerging Company Profile

PhageTech: Classic phage-turner

...find new treatments have been only marginally successful due to a lack of new targets. PhageTech...
...Inc. is approaching the problem by taking lessons from an old pro - the bacteriophage. PhageTech...
...phage open reading frames (ORFs), which designate the base pair triplets (codons) for gene transcription. PhageTech...
BioCentury | Jun 30, 2003
Company News

PhageTech management update

PhageTech Inc. , Montreal, Quebec Business: Genomics, Infectious diseases Hired: Pierre Etienne as CEO and president, formerly VP of worldwide development operations at Pfizer Inc. ; he replaces Dalal Manoli WIR Staff Infectious...
BioCentury | Jun 23, 2003
Company News

PhageTech names Etienne CEO

...Antibacterial company PhageTech (Montreal, Quebec) hired Pierre Etienne as president and CEO. Etienne most recently was...
BioCentury | Mar 24, 2003
Company News

PhageTech board of directors update

PhageTech Inc. , Montreal, Quebec Business: Genomics, Infectious diseases Appointed: Francois Legault, former EVP of corporate development and investments at Biochem Pharma Inc., which is now part of Shire Pharmaceuticals Group plc; and Rene Kurth, senior...
Items per page:
1 - 10 of 16